AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 160 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,491,000 | +969.1% | 164,647 | +430.2% | 0.00% | – |
| Q2 2022 | $233,000 | -18.0% | 31,051 | -0.9% | 0.00% | – |
| Q1 2022 | $284,000 | +38.5% | 31,347 | +7.0% | 0.00% | – |
| Q4 2021 | $205,000 | -57.5% | 29,291 | -30.6% | 0.00% | – |
| Q3 2021 | $482,000 | -22.8% | 42,213 | +8.5% | 0.00% | – |
| Q2 2021 | $624,000 | -28.6% | 38,923 | -20.5% | 0.00% | – |
| Q1 2021 | $874,000 | +53.9% | 48,949 | +16.5% | 0.00% | – |
| Q4 2020 | $568,000 | +59.1% | 42,027 | +38.6% | 0.00% | – |
| Q3 2020 | $357,000 | -94.2% | 30,316 | -92.7% | 0.00% | -100.0% |
| Q2 2020 | $6,111,000 | +1348.1% | 414,016 | +1223.7% | 0.00% | – |
| Q1 2020 | $422,000 | -43.5% | 31,276 | +1.2% | 0.00% | -100.0% |
| Q4 2019 | $747,000 | -81.7% | 30,915 | -85.4% | 0.00% | -66.7% |
| Q3 2019 | $4,075,000 | -15.5% | 212,041 | +29.9% | 0.00% | -25.0% |
| Q2 2019 | $4,825,000 | +216.0% | 163,288 | +408.1% | 0.00% | +300.0% |
| Q1 2019 | $1,527,000 | +41.9% | 32,134 | +7.8% | 0.00% | 0.0% |
| Q4 2018 | $1,076,000 | -92.9% | 29,808 | -87.9% | 0.00% | -92.9% |
| Q3 2018 | $15,102,000 | -5.7% | 245,346 | +3.5% | 0.01% | -12.5% |
| Q2 2018 | $16,015,000 | -10.6% | 237,083 | -28.2% | 0.02% | -5.9% |
| Q1 2018 | $17,916,000 | +67.0% | 330,260 | +84.0% | 0.02% | +70.0% |
| Q4 2017 | $10,725,000 | +89.0% | 179,503 | +53.7% | 0.01% | +66.7% |
| Q3 2017 | $5,676,000 | +92.5% | 116,789 | +108.1% | 0.01% | +100.0% |
| Q2 2017 | $2,949,000 | -22.8% | 56,111 | -33.4% | 0.00% | 0.0% |
| Q1 2017 | $3,822,000 | +56.8% | 84,301 | +30.9% | 0.00% | +50.0% |
| Q4 2016 | $2,438,000 | +156.4% | 64,416 | +155.6% | 0.00% | +100.0% |
| Q3 2016 | $951,000 | +47.2% | 25,198 | -31.3% | 0.00% | 0.0% |
| Q2 2016 | $646,000 | -28.9% | 36,693 | -50.8% | 0.00% | 0.0% |
| Q1 2016 | $908,000 | -13.9% | 74,611 | +72.4% | 0.00% | 0.0% |
| Q4 2015 | $1,054,000 | +341.0% | 43,284 | +220.2% | 0.00% | – |
| Q3 2015 | $239,000 | -68.3% | 13,518 | -68.3% | 0.00% | -100.0% |
| Q2 2015 | $753,000 | +0.3% | 42,640 | +78.0% | 0.00% | 0.0% |
| Q1 2015 | $751,000 | +11.4% | 23,952 | +3.8% | 0.00% | 0.0% |
| Q4 2014 | $674,000 | +143.3% | 23,067 | +106.4% | 0.00% | – |
| Q2 2014 | $277,000 | -25.1% | 11,175 | -35.9% | 0.00% | – |
| Q1 2014 | $370,000 | – | 17,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|